S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
This Stock Could Go Up 66% or More. (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
TSE:EXE

Extendicare (EXE) Stock Forecast, Price & News

C$6.12
-0.01 (-0.16%)
(As of 09/22/2023 08:53 PM ET)
Compare
Today's Range
C$6.11
C$6.17
50-Day Range
C$6.09
C$7.56
52-Week Range
C$6.02
C$7.64
Volume
56,600 shs
Average Volume
142,774 shs
Market Capitalization
C$515.79 million
P/E Ratio
204.00
Dividend Yield
7.84%
Price Target
C$7.33

Extendicare MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
19.8% Upside
C$7.33 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.13 out of 5 stars


EXE stock logo

About Extendicare (TSE:EXE) Stock

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates LTC homes and retirement communities, as well as home health care operations under the Extendicare, ParaMed, Extendicare Assist, and SGP Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

EXE Price History

EXE Stock News Headlines

Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
EXE.TO - Extendicare Inc.
Extendicare Announces Closing of Transaction with Axium
Closing Bell: Extendicare Inc flat on Monday (EXE)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
3 Dividend Stocks to Buy for Income
This 6.5% Dividend Stock Pays You Every Month!
Closing Bell: Extendicare Inc down on Tuesday (EXE)
Extendicare Announces 2023 First Quarter Results
Closing Bell: Extendicare Inc flat on Friday (EXE)
See More Headlines
Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Company Calendar

Last Earnings
8/10/2023
Ex-Dividend for 9/15 Dividend
8/30/2023
Dividend Payable
9/15/2023
Today
9/24/2023
Ex-Dividend for 10/16 Dividend
9/28/2023
Dividend Payable
10/16/2023
Next Earnings (Estimated)
11/09/2023

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
23,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$7.33
High Stock Price Forecast
C$7.50
Low Stock Price Forecast
C$7.00
Forecasted Upside/Downside
+19.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
C$1.47 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.25 billion
Cash Flow
C$1.91 per share
Book Value
C$1.09 per share

Miscellaneous

Free Float
N/A
Market Cap
C$515.79 million
Optionable
Not Optionable
Beta
1.17
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Michael R. Guerriere M.D. (Age 59)
    MBA, CEO, Pres & Director
    Comp: $1.11M
  • Mr. David E. Bacon
    Sr. VP & CFO
  • Mr. John Toffoletto
    Sr. VP, Chief Legal Officer & Corp. Sec.
  • Dr. Matthew Morgan
    Chief Medical Officer
  • Mr. Steve Paraskevopoulos
    Sr. VP of ParaMed & CTO
  • Ms. Jillian E. Fountain
    VP of Investor Relations
  • Ms. Lisa Pearson
    VP of Public Affairs
  • Ms. Kathryn Killoran Bradley
    VP of Corp. Devel.
  • Katie LeMoyne
    Sr. VP & Chief HR Officer
  • Ms. Wendy Gilmour
    Sr. VP of LTC Operations













EXE Stock - Frequently Asked Questions

Should I buy or sell Extendicare stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
View EXE analyst ratings
or view top-rated stocks.

What is Extendicare's stock price forecast for 2023?

3 equities research analysts have issued twelve-month price targets for Extendicare's stock. Their EXE share price forecasts range from C$7.00 to C$7.50. On average, they predict the company's share price to reach C$7.33 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for EXE
or view top-rated stocks among Wall Street analysts.

How have EXE shares performed in 2023?

Extendicare's stock was trading at C$6.56 at the beginning of the year. Since then, EXE stock has decreased by 6.7% and is now trading at C$6.12.
View the best growth stocks for 2023 here
.

When is Extendicare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our EXE earnings forecast
.

How were Extendicare's earnings last quarter?

Extendicare Inc. (TSE:EXE) issued its quarterly earnings data on Thursday, August, 10th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.06. The company earned $307.54 million during the quarter. Extendicare had a trailing twelve-month return on equity of 1.16% and a net margin of 0.60%.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare declared a monthly dividend on Friday, September 15th. Stockholders of record on Friday, September 29th will be paid a dividend of 0.04 per share on Monday, October 16th. This represents a $0.48 dividend on an annualized basis and a yield of 7.84%. The ex-dividend date of this dividend is Thursday, September 28th.
Read our dividend analysis for EXE
.

Is Extendicare a good dividend stock?

Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 7.83%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 1,600.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for EXE.

What other stocks do shareholders of Extendicare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA).

What is Extendicare's stock symbol?

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."

How do I buy shares of Extendicare?

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Extendicare's stock price today?

One share of EXE stock can currently be purchased for approximately C$6.12.

How much money does Extendicare make?

Extendicare (TSE:EXE) has a market capitalization of C$515.79 million and generates C$1.25 billion in revenue each year. The company earns C$1.47 million in net income (profit) each year or C$0.03 on an earnings per share basis.

How many employees does Extendicare have?

The company employs 23,000 workers across the globe.

How can I contact Extendicare?

Extendicare's mailing address is 3000 Steeles Avenue East, Suite 700, Markham, ON L3R 4T9, Canada. The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000.

This page (TSE:EXE) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -